Risk stratification by combining common genetic mutations and TERT promoter methylation in papillary thyroid cancer.

This study suggested that comprehensively analysis of BRAF/RAS mutations, TERT promoter mutation and methylation is an effective strategy to identify high-risk patients with PTC.